Jean-Pierre Sommadossi

President, CEO, and Chairman at Atea Pharmaceuticals · 3 reported transactions in 1 company · latest report Feb 3, 2026

Their trades


Atea PharmaceuticalsAVIR	Exercised options $372K · 300,000 shares	Feb 3, 2026
Atea PharmaceuticalsAVIR	Shares withheld for tax $449.8K · 106,093 shares	Jan 31, 2026
Atea PharmaceuticalsAVIR	Exercised options — · 272,983 shares	Jan 31, 2026

Feb 3, 2026 · AVIR

$372K

Shares withheld for taxAtea Pharmaceuticals

Jan 31, 2026 · AVIR

$449.8K

Jan 31, 2026 · AVIR

272,983

3 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

President, CEO, and Chairman at Atea Pharmaceuticals · 3 reported transactions in 1 company · latest report Feb 3, 2026


Atea PharmaceuticalsAVIR	Exercised options $372K · 300,000 shares	Feb 3, 2026
Atea PharmaceuticalsAVIR	Shares withheld for tax $449.8K · 106,093 shares	Jan 31, 2026
Atea PharmaceuticalsAVIR	Exercised options — · 272,983 shares	Jan 31, 2026

Feb 3, 2026 · AVIR

$372K

Shares withheld for taxAtea Pharmaceuticals

Jan 31, 2026 · AVIR

$449.8K

Jan 31, 2026 · AVIR

272,983

3 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.